Document is current

Article History

Accepted: 21 July 2024

First Online: 24 August 2024

Declarations

:

: Open access funding enabled and organized by CAUL and its Member Institutions. Z.T. was supported by an Australian Government Research Training Program Scholarship and a Macquarie University Australian Pharmaceutical Scholarship during his research candidature at Macquarie University. Five pharmaceutical companies contributed to the Macquarie University Australian Pharmaceutical Scholarship: Amgen Australia, Janssen Australia, MSD Australia, Pfizer Australia, and Roche Australia. No sources of financial assistance were received by S.L., A.N., M.H., and B.P. for this study.

: A.N., M.H., and B.P. are evaluators of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for the Australian Government. S.L. is a full-time employee of Amgen Inc. The views expressed are the authors’ and do not reflect the views of the PBAC, the Australian Government, or Amgen Inc. Z.T. has no (non-funding) conflicts of interest to declare.

: The data used in this analysis are included as an electronic supplement []. The Department of Health and Aged Care owns the copyright in the Pharmaceutical Benefits Advisory Committee (PBAC) Public Summary Documents (PSDs) and Outcomes. These materials are copyright Commonwealth of Australia, used under license.

: Not applicable.

: Not applicable.

: Not applicable.

: The code used in this study can be made available upon request.

: M.H. and Z.T. provided the initial concept of paper, Z.T. and B.P. refined the scope of research, Z.T. gathered data and conducted the analysis. A.N. validated a sample of data. All authors contributed toward the draft and final manuscript.